EcoDrugPlus

Ensembl ID : YMR186W
Description: -
186 Possible Orthologues:

Title

Ensembl ID : YMR199W
Description: -
660 Possible Orthologues:

Title

Ensembl ID : YMR216C
Description: -
214 Possible Orthologues:

Title

Ensembl ID : YMR226C
Description: -
445 Possible Orthologues:

Title

Ensembl ID : YMR242C
Description: -
136 Possible Orthologues:

Title

Ensembl ID : YMR303C
Description: -
249 Possible Orthologues:

Title

Ensembl ID : YMR314W
Description: -
78 Possible Orthologues:

Title

Ensembl ID : YMR318C
Description: -
917 Possible Orthologues:

Title

Ensembl ID : YNL006W
Description: -
73 Possible Orthologues:

Title

Ensembl ID : YNL009W
Description: -
134 Possible Orthologues:

Title

Ensembl ID : YNL021W
Description: -
67 Possible Orthologues:

Title

Ensembl ID : YNL045W
Description: -
72 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).